Weekly Vinorelbine and Oral Capecitabine as Treatment for Stage IV Breast Cancer: A Phase II Trial With Molecular Correlates.
Phase of Trial: Phase II
Latest Information Update: 12 Sep 2012
At a glance
- Drugs Capecitabine; Vinorelbine
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 01 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 Oct 2010 Planned end date changed from 1 Feb 2009 to 1 Mar 2011 as reported by Clinicaltrials.gov.
- 16 Oct 2008 Planned end date changed from May 2008 to Feb 2009 as reported by Clinicaltrials.gov.